Ipsos SA
LSE:0KA3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ipsos SA
LSE:0KA3
|
FR |
|
Tenax Therapeutics Inc
NASDAQ:TENX
|
US |
|
H
|
Henkel AG & Co KGaA
MIL:HEN3
|
DE |
|
Futu Holdings Ltd
NASDAQ:FUTU
|
HK |
|
C
|
Coherent Corp
F:H7B
|
US |
|
D
|
Ducommun Inc
SWB:DUM
|
US |
|
T
|
Tejon Ranch Co
F:2TJ
|
US |
|
Bucher Industries AG
F:BUHA
|
CH |
|
Twin Disc Inc
NASDAQ:TWIN
|
US |
|
L
|
LPKF Laser & Electronics AG
OTC:LPKFF
|
DE |
|
VSE Corp
F:VS3
|
US |
|
A
|
Alpha Pro Tech Ltd
XMUN:APL
|
CA |
|
B
|
Bavarian Nordic A/S
OTC:BVNKF
|
DK |
Wall St Price Targets
0KA3 Price Targets Summary
Ipsos SA
According to Wall Street analysts, the average 1-year price target for 0KA3 is 56.31 EUR with a low forecast of 37.53 EUR and a high forecast of 77.61 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0KA3's stock price target?
Price Target
56.31
EUR
According to Wall Street analysts, the average 1-year price target for 0KA3 is 56.31 EUR with a low forecast of 37.53 EUR and a high forecast of 77.61 EUR.
What is the Revenue forecast for Ipsos SA?
Projected CAGR
3%
Over the last 14 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 3%.
What is the Operating Income forecast for Ipsos SA?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 3 years is 6%.
What is the Net Income forecast for Ipsos SA?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 3 years is 12%.
